Skip to content
DataLookout
Menu

NCT05828030

HFNC Compared With Facial Mask in Patients With Chest Trauma Patients

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Dec 31, 2028 Show 5 more changesShow less
    • Eligibility criteria expanded, about 5 words
    • Enrollment closed, study ongoing
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description revised
    • Site details revised at 2 of 2 sites
  2. Notable Primary completion date: Dec 31, 2024 to Dec 31, 2026
    • Study completion date: Dec 31, 2024 to Dec 31, 2027
    • Site details revised at 2 of 2 sites
    v4
  3. Minor Start date: Apr 25, 2023 to Apr 26, 2023v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 15, 2023 to Apr 25, 2023
    • Site details revised at 2 of 2 sites
    • Study title shortened, about 4 words
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Rate of event of intubation or pneumonia
Timeframe: 30 days after randomization

Secondary (2)

P/F ratio
pneumonia rate /tracheostomy rate

Arms and interventions

high flow nasal cannula groupExperimental

All patients will have FiO2 started at 0.4 and titrated to maintain oxygen saturation (SpO2) ≥ 95%. The flow rate will be set at titrated from 60 L/min.

Oxygen Mask groupActive comparator

All patients will have FiO2 started at 0.4 and titrated to maintain oxygen saturation (SpO2) ≥ 95%.

Procedures: high flow nasal cannula, Oxygen mask

Sites

2 sites in 1 country